EXACT Sciences Corporation (EXAS) stock news · rev $3.25B
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
This EXAS news page leads with what EXACT Sciences Corporation filed — not a scraped headline mill.
No cached 8-K sentence for EXAS yet. We will not pad this page with generic market recap.
Latest reported EXAS revenue for 2025-12-31 was $3.25B. Net income was -$207.9M. Revenue was up 55.8% from 2022-12-31 to 2025-12-31. EXAS currently screens at market cap $20.03B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the EXAS stock page; for the tape open the quote page.
EXAS stock news FAQ
What are EXAS's latest revenue and net income?
Latest cached EXACT Sciences Corporation (EXAS) revenue for Dec 31, 2025 was $3.25B. Net income was -$207.9M. Statements: https://lician.com/financials/exas
How did EXAS revenue change from the prior cached period?
Cached EXACT Sciences Corporation (EXAS) revenue was up 55.8% from $2.08B (Dec 31, 2022) to $3.25B (Dec 31, 2025). Statements: https://lician.com/financials/exas
What is EXAS's market cap?
EXACT Sciences Corporation (EXAS) market cap is $20.03B on the latest cached fundamentals snapshot.
What kind of company is EXAS?
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Where is EXAS stock news listed?
Cached stock news for EXACT Sciences Corporation (EXAS) is listed at https://lician.com/news/exas. Filings: https://lician.com/sec/exas
Not investment advice.